Hyppää sisältöön
    • Suomeksi
    • In English
Trepo
  • Suomeksi
  • In English
  • Kirjaudu
Näytä viite 
  •   Etusivu
  • Trepo
  • Opinnäytteet - ylempi korkeakoulututkinto
  • Näytä viite
  •   Etusivu
  • Trepo
  • Opinnäytteet - ylempi korkeakoulututkinto
  • Näytä viite
JavaScript is disabled for your browser. Some features of this site may not work without it.

Commercialisation and quality requirements of biomedical wearable and implantable devices

Galeti, Ekram (2013)

 
Avaa tiedosto
Galeti.pdf (2.025Mt)
Lataukset: 



Galeti, Ekram
2013

Master's Degree Programme in Biomedical Engineering
Tieto- ja sähkötekniikan tiedekunta - Faculty of Computing and Electrical Engineering
This publication is copyrighted. You may download, display and print it for Your own personal use. Commercial use is prohibited.
Hyväksymispäivämäärä
2013-08-14
Näytä kaikki kuvailutiedot
Julkaisun pysyvä osoite on
https://urn.fi/URN:NBN:fi:tty-201308191282
Tiivistelmä
Due to growing old age population and increase in chronic diseases at all the ages across the world, there is an opportunity for Biomedical device companies for a vital investment and address the problems by introducing risk free, effective, and safe devices into the market. Presently, the market for Biomedical Wearable and Implantable devices is in high demand due to wider applications and advance in computing algorithms in Medical industry.

The current thesis has been focused on commercialising and quality requirements of Biomedical Wearable and Implantable devices by understanding the market requirements and increase in global demand for quality devices. In order to manufacture an effective Biomedical device, manufactures have to establish quality management systems in every phase of product development phase to produce safe and effective devices, and meet the requirements of regulatory authorities who in turn are answerable to the public. These Biomedical devices can extend and give quality life to the patient sufferings.

Though companies see a profitable business for these innovative Biomedical devices, stringent requirements and longer approval time process from regulatory authorities are making the Biomedical device companies to rethink to enter the market in these Biomedical devices. Moreover, regulatory authorities should consider adopting the global nomenclature and standards due to increasing global demand supply chain management for these devices.
Kokoelmat
  • Opinnäytteet - ylempi korkeakoulututkinto [40066]
Kalevantie 5
PL 617
33014 Tampereen yliopisto
oa[@]tuni.fi | Tietosuoja | Saavutettavuusseloste
 

 

Selaa kokoelmaa

TekijätNimekkeetTiedekunta (2019 -)Tiedekunta (- 2018)Tutkinto-ohjelmat ja opintosuunnatAvainsanatJulkaisuajatKokoelmat

Omat tiedot

Kirjaudu sisäänRekisteröidy
Kalevantie 5
PL 617
33014 Tampereen yliopisto
oa[@]tuni.fi | Tietosuoja | Saavutettavuusseloste